In line with our study, some authors reported that increased CTL counts were associated with ER and PR negativity, HER2 overexpression [23–25], and higher Ki67 level [25, 26] in breast cancer, while the results from other publications question these findings [20, 26, 27]. The gene discussed is ERBB2; the disease is breast cancer.